Foghorn Therapeutics Inc. (FHTX) vs Outlook Therapeutics, Inc. (OTLK)

A side-by-side comparison of Foghorn Therapeutics Inc. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FHTX vs OTLK

growth of $100 · dividends reinvested · last 6y
FHTX -89.0% (-30.7%/yr)OTLK -96.0% (-41.5%/yr)FHTX compounded faster over this window
0100200300400Start $100202120222023202420252026$11$4
FHTX OTLK

FHTX vs OTLK: by the numbers

  • •FHTX is the larger company ($114M vs $107M market cap).
  • •Both run net losses; FHTX's is the smaller (-175.78% vs -4416.22% net margin).

Metrics side by side

Valuation

MetricFHTXOTLK
P/S ratio3.09N/A

Profitability

MetricFHTXOTLK
Gross margin89.22%46.49%
Operating margin-265.64%-4744.25%
Net margin-175.78%-4416.22%
ROIC-44.81%-352.19%

Growth (annualized)

MetricFHTXOTLK
Revenue CAGR (5Y)105.83%N/A
Total return CAGR (5Y)-31.87%-57.40%

Frequently asked

How have FHTX and OTLK total returns compared?
Over the past 5 years, FHTX delivered -31.87% and OTLK delivered -57.40% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.